Evgeny Chichelnitskiy
Overview
Explore the profile of Evgeny Chichelnitskiy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
599
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chichelnitskiy E, Goldschmidt I, Ruhl L, Rubsamen N, Jaeger V, Karch A, et al.
J Hepatol
. 2024 May;
81(5):862-871.
PMID: 38821361
Background & Aims: After pediatric liver transplantation (pLT), children undergo life-long immunosuppression since reliable biomarkers for the assessment of rejection probability are scarce. In the multicenter (n = 7) prospective...
2.
CD14CD16 monocytes are the main producers of Interleukin-10 following clinical heart transplantation
Ludwig K, Chichelnitskiy E, Kuhne J, Wiegmann B, Iske J, Ledwoch N, et al.
Front Immunol
. 2023 Nov;
14:1257526.
PMID: 37936714
Introduction: Following heart transplantation, a cascade of immunological responses is initiated influencing the clinical outcome and long-term survival of the transplanted patients. The anti-inflammatory cytokine interleukin-10 (IL-10) was shown to...
3.
Goldschmidt I, Chichelnitskiy E, Gotz J, Rubsamen N, Karch A, Jager V, et al.
Liver Transpl
. 2023 Sep;
30(3):288-301.
PMID: 37678230
Steroid-free immunosuppression protocols gained popularity in pediatric liver transplantation (pLT) after the introduction of IL-2-receptor blockade for induction therapy. We analyzed the clinical and immunologic outcome data of the multicenter...
4.
Sikkema L, Ramirez-Suastegui C, Strobl D, Gillett T, Zappia L, Madissoon E, et al.
Nat Med
. 2023 Jun;
29(6):1563-1577.
PMID: 37291214
Single-cell technologies have transformed our understanding of human tissues. Yet, studies typically capture only a limited number of donors and disagree on cell type definitions. Integrating many single-cell datasets can...
5.
Heise E, Chichelnitskiy E, Greer M, Franz M, Aburahma K, Iablonskii P, et al.
Am J Transplant
. 2023 May;
23(11):1740-1756.
PMID: 37225088
Pretransplant allosensitization to human leukocyte antigens (HLA) increases the recipient's waiting list time and mortality in lung transplantation. Rather than waiting for crossmatch-negative donors, since 2013, recipients with preformed donor-specific...
6.
Iske J, Wiegmann B, Ius F, Chichelnitskiy E, Ludwig K, Kuhne J, et al.
Eur J Immunol
. 2023 Apr;
53(7):e2250097.
PMID: 37119053
Early kinetics of lymphocyte subsets involved in tolerance and rejection following heart transplantation (HTx) are barely defined. Here, we aimed to delineate the early alloimmune response immediately after HTx. Therefore,...
7.
Goldschmidt I, Chichelnitskiy E, Rubsamen N, Jaeger V, Karch A, DAntiga L, et al.
Children (Basel)
. 2023 Jan;
10(1).
PMID: 36670678
Background: The current gold standard to diagnose T-cell-mediated acute rejection (TCMR) requires liver histology. Using data from the ChilSFree study on immune response after paediatric liver transplantation (pLT), we aimed...
8.
Sommer W, Avsar M, Aburahma K, Salman J, Kaufeld K, Rojas S, et al.
Am J Transplant
. 2022 Apr;
22(8):2064-2076.
PMID: 35426974
Heart transplantation across preformed donor-specific HLA-antibody barriers is associated with impaired short- and long-term survival. Therefore, in recipients with preformed anti-HLA antibodies, waiting for crossmatch-negative donors is standard practice. As...
9.
Hitz A, Blasing K, Wiegmann B, Bellmas-Sanz R, Chichelnitskiy E, Wandrer F, et al.
Front Immunol
. 2021 Dec;
12:778885.
PMID: 34966390
Introduction: For end-stage lung diseases, double lung transplantation (DLTx) is the ultimate curative treatment option. However, acute and chronic rejection and chronic dysfunction are major limitations in thoracic transplantation medicine....
10.
Ledwoch N, Wiegmann B, Chichelnitskiy E, Wandrer F, Kuhne J, Beushausen K, et al.
Cytokine
. 2021 Oct;
149:155744.
PMID: 34649160
Background: Ischemia/reperfusion injury (IRI) is associated with inflammatory responses contributing to the development of primary graft dysfunction (PGD) and rejection. Here, we investigated the pathophysiology of IRI and the early...